TANSTAAFL
A bit off the beaten path today. . . "There ain't no such thing as a free lunch" or TANSTAAFL is a phrase that's been around maybe a century but popularized by author Robert Heinlein first in his novel The Moon is a Harsh Mistress in 1966. If you "grok" (think about) it a bit, it can present an important life lesson...
We've already been kicked in the teeth with the news of our diagnosis. It would not be a problem if you could take a simple pill to make it disappear. But TANSTAAFL - we can't and treatment most often involves a hard journey. And once we complete that journey, no one can take away the courage and hard work that we have won. No one waved a wand and made it disappear, we work(ed) hard through treatment.
The next time someone says "oh, you only had lymphoma, not a tough cancer" - shout TANSTAFFL and look at them like they're from another planet. Cancer is the big leagues, no matter what it is. And we're in this to win.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
